BioClinica Shareholders Can't Stop $123M PE Takeover Bid
BioClinica's board announced Jan. 29 that it had accepted a $7.25-per-share buyout offer from PE firm JLL Partners Inc., and investors brought multiple suits in Delaware Chancery Court seeking to hold up the transaction, which the parties expect to conclude March 11.
Vice Chancellor Sam Glasscock III credited...
Already a subscriber? Click here to login